Five details:
1. Three private equity firms, Blackstone, Carlyle and Hellman & Friedman, partnered with Singapore’s sovereign wealth fund GIC for a majority investment in Medline, the companies announced June 5.
2. The transaction, valued at more than $30 billion according to The Wall Street Journal, is expected to close in late 2021.
3. In 2020, Medline reported $17.5 billion in revenue and the company plans to use the new funds to expand product offerings, grow faster internationally and invest in global supply chain infrastructure.
4. Post-transaction, the Mills family will still be the largest single shareholder and Medline will remain a privately held, family-led company. The senior management team is staying entact.
5. This investment in Medline is the largest leveraged buyout in more than 10 years, according to the Journal.
